How DeepLook Medical is Transforming Women’s Health

Enhancing Medical Imaging with Revolutionary Software

40% of women have dense breast tissue and require additional screening after a mammogram

Breast cancer is the second most deadly cancer for women. Being able to detect it, and detect it early, is crucial for protecting women. But, for some women, the technology used for imaging falls short. 

Breasts are made up of mostly fat tissue. However, about 40% of women have dense breasts, meaning that there is less fatty tissue and a higher amount of dense types of tissue, such as glandular and fibrous connective tissue. Dense breast tissue alone is not an alarming characteristic. However, it makes a woman up to three times more likely to develop breast cancer.

Getting proper imaging done is challenging for women with dense breasts. There are billions of dollars spent on additional imaging or diagnostics after an initial mammogram, simply because the imaging is not clear enough to rule out problems. To add to the complexity of the issue, there is a shortage of qualified radiologists, contributing to frequent missed diagnoses among women with dense breasts.

The DeepLook Medical Solution

DeepLook Medical wants to change the quality of imaging for patients and doctors alike. Their data-driven technology can be used with mammogram, MRI, CT scan and ultrasound. DeepLook’s software, DL Precise™ is FDA cleared, and improves the quality of diagnostic imagery by utilizing cloud-enabled image viewers and leverages AI-driven shape recognition to streamline detection of abnormalities for practitioners. 

Marissa Fayer, CEO of DeepLook Medical is an experienced leader with a strong track record of getting diagnostic technology to women who need it. She has been recognized as one of the top 100 women in Medtech by, and under her leadership, DeepLook Medical has been recognized as a top Woman-Led Start-up in Medtech.

How Femovate Helps

DeepLook Medical was awarded sponsorship through Guidea’s Femovate program for ‘22-’24.

As part of the Femovate sponsorship, the digital health experts at Guidea are working with Marissa Fayer and her team to improve the user experience for radiologists, optimizing and refining the digital design for DeepLook’s software, DL Precise™.

For more information about DeepLook Medical, visit and follow them on LinkedIn

For more information on Femovate visit and follow us on LinkedIn

For interviews please contact Theresa Neil

Stay in touch

The application period for Femovate 2023-24 is now closed. Follow us on LinkedIn for updates and the selected startups announcement.